HSA — authorised 12 September 2003
- Marketing authorisation holder: CUBIST
- Status: likely_approved
HSA authorised Cubicin on 12 September 2003
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 12 September 2003.
CUBIST holds the Singaporean marketing authorisation.